Cargando…

Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib

Glioblastoma is an aggressive form of central nervous system tumor. Recurrence rates following primary therapy are high, and few second-line treatment options provide durable clinical benefit. Aberrations of the epidermal growth factor receptor (EGFR) gene are observed in up to 57% of glioblastoma c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owen, Scott, Alken, Scheryll, Alshami, Jad, Guiot, Marie-Christine, Kavan, Petr, Reardon, David A, Muanza, Thierry, Gibson, Neil, Pemberton, Karine, Solca, Flavio, Cseh, Agnieszka, Saran, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005142/ https://www.ncbi.nlm.nih.gov/pubmed/35422631 http://dx.doi.org/10.2147/OTT.S346725

Ejemplares similares

Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: A case report
por: Alshami, Jad, et al.
Publicado: (2015)

Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
por: Saran, Frank, et al.
Publicado: (2021)

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation
por: Zöchbauer-Müller, Sabine, et al.
Publicado: (2021)

Benefit risk assessment and update on the use of docetaxel in the management of breast cancer
por: Alken, Scheryll, et al.
Publicado: (2013)

A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
por: Modjtahedi, Helmout, et al.
Publicado: (2014)

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
por: Lu, Shun, et al.
Publicado: (2018)

A permanent legacy of the pandemic? Outcomes of and staff views on the introduction of virtual clinics to an Irish oncology service
por: Kieran, Ruth, et al.
Publicado: (2022)

Efficacy and Safety Results of the Afatinib Expanded Access Program
por: Kim, Edward S., et al.
Publicado: (2017)

Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors
por: Ribeiro Gomes, Jéssica, et al.
Publicado: (2015)

Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo
por: Young, Natalie R., et al.
Publicado: (2015)

A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors
por: Spicer, James, et al.
Publicado: (2016)

Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
por: Yang, James Chih-Hsin, et al.
Publicado: (2022)

Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
por: Ioannou, N, et al.
Publicado: (2011)

Monocyte-neutrophil entanglement in glioblastoma
por: Friedmann-Morvinski, Dinorah, et al.
Publicado: (2023)

Targeting fatty acid metabolism in glioblastoma
por: Miska, Jason, et al.
Publicado: (2023)

Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study
por: Thongprasert, Sumitra, et al.
Publicado: (2019)

Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
por: Khan, Fatima, et al.
Publicado: (2023)

A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
por: O’Brien, Mary E. R., et al.
Publicado: (2018)

A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice
por: Slobbe, Paul, et al.
Publicado: (2015)

Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib
por: Hochmair, Maximilian J., et al.
Publicado: (2018)

Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats
por: Zhang, Li, et al.
Publicado: (2023)

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
por: Vengoji, Raghupathy, et al.
Publicado: (2019)

Pulmonary aspergillosis: diagnosis and treatment
por: Lamoth, Frederic, et al.
Publicado: (2022)

Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy
por: Bergot, Emmanuel, et al.
Publicado: (2013)

Small cell glioblastoma multiforme: a case series and clinicopathological update
por: Yadav, Arun Kumar, et al.
Publicado: (2020)

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
por: Arrieta, Víctor A., et al.
Publicado: (2023)

Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
por: Wind, Sven, et al.
Publicado: (2016)

Pulmonary rehabilitation and physical interventions
por: Troosters, Thierry, et al.
Publicado: (2023)

Asthma remission: what is it and how can it be achieved?
por: Thomas, Dennis, et al.
Publicado: (2022)

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
por: Singh, Sally J, et al.
Publicado: (2023)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab
por: Hwang, Helen, et al.
Publicado: (2022)

“Liquid elbows” due to afatinib administration
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Familial glioblastoma clustering in adult patients: a case report of two non-twin siblings and review of the literature
por: Sander, Caroline, et al.
Publicado: (2019)

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial
por: Goss, Glenwood D, et al.
Publicado: (2021)

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
por: Cohen, E. E. W., et al.
Publicado: (2017)

Visual field changes as an early indicator of glioblastoma multiforme progression: two cases of functional vision changes before MRI detection
por: Xie, Kate, et al.
Publicado: (2015)

Evaluation of Alvarado score in diagnosing acute appendicitis
por: Awayshih, Mahmoud Musa Al, et al.
Publicado: (2019)

Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults
por: Dombret, Marie-Christine, et al.
Publicado: (2014)

Afatinib in Non–Small Cell Lung Cancer
por: Wirth, Scott M.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rq643glhd4tchtveqruiehmtdg